
HbA1c –Marker for Long Term Glycemic Control
Author(s) -
Ajay Puri,
Jyoti Kohli,
V.J. Chrunjoo
Publication year - 2020
Publication title -
asian journal of medical research
Language(s) - English
Resource type - Journals
eISSN - 2347-3398
pISSN - 2277-7253
DOI - 10.47009/ajmr.2020.9.1.bc1
Subject(s) - glycation , glycemic , medicine , glycated hemoglobin , diabetes mellitus , type 2 diabetes mellitus , endocrinology , hemoglobin , pathogenesis , metabolic control analysis , type 2 diabetes
Background: Protein glycation is a spontaneous reaction that is believed to play a key role in the pathogenesis of many clinical disorders. The glycation of proteins is enhanced by elevated blood glucose concentrations. The major form of protein glycation with a clinical consideration is glycatedhaemoglobin (HbA1c). HbA1c is majorly affected by the blood glucose levels alone. Diabetes mellitus is a metabolic disorder characterized by hyperglycemia. Studies have suggested that HbA1c levels in type-2 diabetes mellitus patients mostly remains elevated, yet some such patients, with or without tight glycemic control, have HbA1c levels nearly close to or within the normal reference range.Subjects and Methods:In this study HbA1c, fasting blood glucose levels and post prandial blood glucose levels in normal subjects as well as in patients with Type-2 diabetes mellitus excluding the complicated ones were studied.Results:The present study confirms earlier studies that all these levels are tightly correlated and the corresponding p values were < 0.001 which were significant and was estimated by using student t-test.Conclusion: Thus indicating that glycated hemoglobin (HbA1c) can be used to assess the glycemic status of an individual for attaining the treatment goal of preventing long term complications of diabetes mellitus.